Large Scale Biology Corporation in Agreement With Schering-Plough Animal Health on Animal Vaccines.Business Editors/Health/Medical Writers VACAVILLE, Calif.--(BUSINESS WIRE)--Oct. 28, 2003 Large Scale Biology Corporation (Nasdaq:LSBC LSBC Law Society of British Columbia LSBC Large Scale Biology Corporation LSBC Lone Star Bulldog Club LSBC Lasalle & Bureau County Railroad Company LSBC Lifesaver for Babies and Children (St John Ambulance, UK) LSBC Lone Star Bit Company ) today announced an exclusive collaborative agreement with Schering-Plough Animal Health Corporation (SPAH SPAH Schering-Plough Animal Health Corporation ), the worldwide animal health care business of Schering-Plough Corporation, to evaluate several vaccines for control of viral infections viral infection, n an infection by a pathogenic virus. A virus acts on the cell nucleus, taking over the genetic material within the nucleus and replicating itself. in animals. Under the terms of the agreement, Large Scale Biology Corporation (LSBC) will produce trial quantities of vaccine antigens using its proprietary GENEWARE(R) biomanufacturing platform and SPAH will evaluate the vaccines for efficacy and safety in clinical models. The agreement includes a research program and, upon its successful completion, an option for a toll manufacturing agreement under which LSBC would manufacture and supply vaccine products for clinical trials and commercialization by SPAH. Financial details of the agreement were not disclosed. LSBC's GENEWARE(R) biomanufacturing platform technology provides a method for producing animal health vaccines using non-GMO (genetically modified organisms ge·net·i·cal·ly modified organism n. Abbr. GMO An organism whose genetic characteristics have been altered by the insertion of a modified gene or a gene from another organism using the techniques of genetic engineering. ) non-food plants as a production host. "We welcome this relationship with SPAH, a world leader in animal health," said Kevin J. Ryan, President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of LSBC. "This collaboration is expected to provide additional validation for our unique biomanufacturing technology, creating solid product development and manufacturing opportunities." "Schering-Plough has broad experience and proven expertise in applying new technologies in the development of animal health products," said Dr. K.J. Varma, Vice President, Research and Development, Schering-Plough Animal Health. "This collaboration with LSBC will explore new approaches to developing and manufacturing vaccines, further strengthening our position in the growing and important vaccine segment of the animal health business." About Schering-Plough Animal Health Schering-Plough Animal Health Corporation is the worldwide animal health care business of Schering-Plough Corporation (NYSE NYSE See: New York Stock Exchange :SGP SGP Singapore (ISO Country code) SGP Schering-Plough (stock symbol) SGP Stability and Growth Pact SGP Southern Great Plains SGP Staatkundig Gereformeerde Partij SGP Speedway Grand Prix ) of Kenilworth, N.J., a research-based company engaged in the discovery, development, manufacturing and marketing of pharmaceutical products worldwide. About Large Scale Biology Corporation Large Scale Biology uses its biomanufacturing, functional genomics Noun 1. functional genomics - the branch of genomics that determines the biological function of the genes and their products genomics - the branch of genetics that studies organisms in terms of their genomes (their full DNA sequences) and proteomics technologies to develop and manufacture drugs and vaccines for effective treatment of disease. Corporate offices, the Genomics Division and Biopharmaceutical Development laboratories are headquartered in Vacaville, California Vacaville, California is located in Solano County, California, United States, between Sacramento and San Francisco. As of the 2000 census, the city had a total population of 88,625. ; the Company's Proteomics Division is located in Germantown, Maryland; and the Company's commercial-scale biomanufacturing facility is located in Owensboro, Kentucky Owensboro is the third largest city in Kentucky and the county seat of Daviess County.GR6 It is located on U.S. Highway 60 about 32 miles southeast of Evansville, Indiana and is the principal city of the Owensboro, Kentucky Metropolitan Statistical Area. . For more information about Large Scale Biology Corporation, visit the Company's website at www.lsbc.com. This release contains forward-looking statements forward-looking statement A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections. about an application of LSBC's technologies and the market for one of our products. These forward-looking statements involve risks, uncertainties and situations that may cause our actual results to differ materially from those implied by these statements, including our ability to produce adequate quantities of product, the ability of our collaborators to generate demand for products we make for them, the effectiveness of our and our collaborators' technologies to produce specific therapeutic products and/or in a cost-effective manner, any difficulties or delays in obtaining regulatory approval to test and market such products, and the requirement of substantial funding for us to preserve our technology base and product pipeline. We cannot guarantee future results. You should not place undue reliance on these forward-looking statements, which apply only as of the date of this release. For a further list and description of such risks and uncertainties see the reports filed by Large Scale Biology Corporation with the Securities and Exchange Commission, including our reports on Forms 10-K and 10-Q. Except as required by law, we do not undertake to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise. LSBC(TM) is a trademark of Large Scale Biology Corporation. GENEWARE(R) is a registered trademark of Large Scale Biology Corporation. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion